Lyophilisable and Air Dryable
COVID-19
qPCR
NGS
PCR
cDNA Synthesis
DNA Extraction
Isothermal Amplification
PCR Biosystems was founded in 2012 by two PCR experts who believed scientists deserved better performance and value from their PCR products. We wanted to do things differently.
We’ve developed a range of PCR reagents that maximise yield and sensitivity from the simplest to most challenging of reactions. On average, our products outperform every competitor in terms of yield, specificity, sensitivity and speed. So your reactions have the best chance of working the way you want, first time.
We’re a UK-based company, with an international team and a global sales force (38 distributors and counting). Our focus is on PCR and nothing else. Because we don’t rely on shareholders or venture capitalists, it lets us invest a large proportion of our profits into R&D: helping us make new reagents – and improve on the ones we already have.